University of Oxford researchers have been awarded \u00a31.24 million to lead a medical diagnostics co-operative that will drive forward the development, evaluation and uptake of new medical diagnostic technologies to improve outcomes for patients in the community.
On Friday 25th November, the Diagnostic Evidence Co-operative launched the first of a series of seminars to explore wearable technologies, imaging devices and digital health related technologies.
Using a simple decision rule and a finger prick to test blood, general practitioners could substantially reduce the number of ill children being referred to hospital, if the test is used on children identified as \u2018at-risk\u2019 of a serious infection.
The latest call from Innovate SBRI has three main focus areas:\r\n1. General practice workload and demand management\r\n2, General practice - diagnostics and earlier triage\r\n3. General practice - self-care\r\n\r\nPlease contact Philip Turner at DEC Oxford if you are developing technology which might address any of these areas and would like to discuss a colllaborative application.
Researchers from the Oxford University Clinical Research Unit in Vietnam have shown that using a rapid (5-minute) test can reduce antibiotic misuse for respiratory infections. Cutting the number of unnecessary antibiotic prescriptions is a key way to prevent the spread of antibiotic-resistant infections.
DECisions, the boardgame which illustrates the evidence gathering and regulatory pathway that diagnostic test must follow in order for the device to be implemented in clinical practice, won first prize in the category 'Most innovative research poster' at this year's OxTalent awards.
Antimicrobial resistance and the threat of 'superbugs' recently hit the headlines. Researchers from DEC Oxford contributed to the paper which you can read in full below.
Dr Ann Van den Bruel, Director of the Diagnostic Evidence Co-operative Oxford on disruptive diagnostics; the theme of this year's UK Diagnostics Forum.
As part of the NIHR infrastructure, DEC Oxford were invited to host a stand at the BRC's public open day, held at the John Radcliffe Hospital on Thursday 21st April.
The annual NIHR Diagnostic Evidence Co-operative (DEC) Oxford Workshop took place at Worcester College, Oxford over two days last week, and was a sell out!
Dr Ann Van den Bruel, Associate Professor and Director of DEC Oxford is profiled in Oxford MedSci News, the newsletter for the Medical Sciences Division.
A survey published in the BMJ, funded by the NIHR DEC Oxford, shows people have highly variable views, with patients accepting more overdetection in cancer screening when a higher benefit was perceived.
![\"The](\"https://www.community.healthcare.mic.nihr.ac.uk/news/ps1-24-million-for-new-medical-diagnostics-hub/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n